ADMA
Price
$17.44
Change
-$0.19 (-1.08%)
Updated
Aug 19 closing price
Capitalization
4.16B
77 days until earnings call
NVCT
Price
$6.14
Change
-$0.31 (-4.81%)
Updated
Aug 19 closing price
Capitalization
156.31M
83 days until earnings call
Interact to see
Advertisement

ADMA vs NVCT

Header iconADMA vs NVCT Comparison
Open Charts ADMA vs NVCTBanner chart's image
ADMA Biologics
Price$17.44
Change-$0.19 (-1.08%)
Volume$2.61M
Capitalization4.16B
Nuvectis Pharma
Price$6.14
Change-$0.31 (-4.81%)
Volume$65.87K
Capitalization156.31M
ADMA vs NVCT Comparison Chart in %
Loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADMA vs. NVCT commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Hold and NVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (ADMA: $17.44 vs. NVCT: $6.14)
Brand notoriety: ADMA and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 78% vs. NVCT: 34%
Market capitalization -- ADMA: $4.16B vs. NVCT: $156.31M
ADMA [@Biotechnology] is valued at $4.16B. NVCT’s [@Biotechnology] market capitalization is $156.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.19B to $0. The average market capitalization across the [@Biotechnology] industry is $1.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ADMA is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 1 TA indicator(s) are bullish while NVCT’s TA Score has 4 bullish TA indicator(s).

  • ADMA’s TA Score: 1 bullish, 8 bearish.
  • NVCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVCT is a better buy in the short-term than ADMA.

Price Growth

ADMA (@Biotechnology) experienced а +4.06% price change this week, while NVCT (@Biotechnology) price change was -9.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.66%. For the same industry, the average monthly price growth was +26.06%, and the average quarterly price growth was +20.46%.

Reported Earning Dates

ADMA is expected to report earnings on Nov 05, 2025.

NVCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.16B) has a higher market cap than NVCT($156M). NVCT YTD gains are higher at: 13.494 vs. ADMA (1.691). ADMA has higher annual earnings (EBITDA): 163M vs. NVCT (-22.97M). ADMA has more cash in the bank: 90.3M vs. NVCT (26.8M). ADMA has higher revenues than NVCT: ADMA (474M) vs NVCT (0).
ADMANVCTADMA / NVCT
Capitalization4.16B156M2,668%
EBITDA163M-22.97M-710%
Gain YTD1.69113.49413%
P/E Ratio20.52N/A-
Revenue474M0-
Total Cash90.3M26.8M337%
Total Debt83.8MN/A-
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMANVCT
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 30 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMAJX10.300.04
+0.39%
American Century Small Cap Dividend R
LMCHX32.92N/A
N/A
Lord Abbett Mid Cap Stock R6
HAINX54.74-0.04
-0.07%
Harbor International Institutional
JMNSX16.10-0.04
-0.25%
JPMorgan Research Market Neutral I
VEMPX373.23-3.12
-0.83%
Vanguard Extended Market Index InstlPlus

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IMTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-1.08%
IMTX - ADMA
42%
Loosely correlated
-9.98%
IMNM - ADMA
40%
Loosely correlated
-2.24%
SYRE - ADMA
38%
Loosely correlated
-4.90%
RYTM - ADMA
38%
Loosely correlated
-0.92%
RLAY - ADMA
38%
Loosely correlated
-2.02%
More

NVCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCT has been loosely correlated with PDSB. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCT jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-4.81%
PDSB - NVCT
33%
Loosely correlated
-5.65%
ADMA - NVCT
30%
Poorly correlated
-1.08%
CSCI - NVCT
29%
Poorly correlated
-9.00%
SGMT - NVCT
28%
Poorly correlated
-8.48%
CLDI - NVCT
27%
Poorly correlated
-26.83%
More